Protein transfer of glycosyl-phosphatidylinositol-B7-1 into tumor cell membranes: a novel approach to tumor immunotherapy.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Cancer Research

• Publication date

  1999-05-15

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 10344754
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Transfer of exogenous glycosylphos-phatidylinositol (GPI)-linked molecules to plasma membranes.

  1996cited by this paper
• Cell‐surface engineering with GPI‐anchored proteins

  1996cited by this paper
• B7-1 and interleukin 12 synergistically induce effective antitumor immunity.

  1995cited by this paper
• Glycosylphosphatidylinositol-modified murine B7-1 and B7-2 retain costimulator function.

  1995cited by this paper
• Paracrine cytokine adjuvants in cancer immunotherapy.

  1995cited by this paper
• Purification and optimization of functional reconstitution on the surface of leukemic cell lines of GPI-anchored Fc gamma receptor III.

  1995cited by this paper
• Construction, purification, and functional incorporation on tumor cells of glycolipid-anchored human B7-1 (CD80).

  1995cited by this paper
• Rejection of murine melanoma-cells transfected with the intercellular-adhesion molecule-1 gene.

  1995cited by this paper
• Effective tumor vaccine generated by fusion of hepatoma cells with activated B cells.

  1994cited by this paper
• Protein transfer of preformed MHC-peptide complexes sensitizes target cells to T cell cytolysis.

  1994influential reference
• B7-1/CD80-transduced tumor cells elicit better systemic immunity than wild-type tumor cells admixed with Corynebacterium parvum.

  1994cited by this paper
• Interleukin-12: a cytokine produced by antigen-presenting cells with immunoregulatory functions in the generation of T-helper cells type 1 and cytotoxic lymphocytes.

  1994cited by this paper
• Specificity and longevity of antitumor immune responses induced by B7-transfected tumors.

  1994cited by this paper
• Human T-cell clonal anergy is induced by antigen presentation in the absence of B7 costimulation.

  1993cited by this paper
• Induction of alloantigen-specific hyporesponsiveness in human T lymphocytes by blocking interaction of CD28 with its natural ligand B7/BB1

  1993cited by this paper
• Tumor rejection after direct costimulation of CD8+ T cells by B7-transfected melanoma cells.

  1993cited by this paper
• Constitutive expression of B7 restores immunogenicity of tumor cells expressing truncated major histocompatibility complex class II molecules.

  1993cited by this paper
• Plasmid DNA Is Superior to Viral Vectors for Direct Gene Transfer into Adult Mouse Skeletal Muscle

  1993cited by this paper
• Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4.

  1992cited by this paper
• CD28 interaction with B7 costimulates primary allogeneic proliferative responses and cytotoxicity mediated by small, resting T lymphocytes

  1992cited by this paper
• Prolonged survival of thymoma-bearing mice after vaccination with a soluble protein antigen entrapped in liposomes: a model study.

  1992cited by this paper
• Transduction of a foreign histocompatibility gene into the arterial wall induces vasculitis.

  1992cited by this paper
• Membranes from both Th1 and Th2 T cell clones stimulate B cell proliferation and prepare B cells for lymphokine-induced differentiation to secrete Ig.

  1991cited by this paper
• Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and interleukin 2 mRNA accumulation

  1991cited by this paper
• CD28 ligation in T-cell activation: evidence for two signal transduction pathways.

  1990cited by this paper
• Clonal expansion versus functional clonal inactivation: a costimulatory signalling pathway determines the outcome of T cell antigen receptor occupancy.

  1989cited by this paper
• Introduction of soluble protein into the class I pathway of antigen processing and presentation.

  1988cited by this paper
• The major Fc receptor in blood has a phosphatidylinositol anchor and is deficient in paroxysmal nocturnal haemoglobinuria

  1988cited by this paper
• Stimulation of B-cell proliferation by membrane-associated molecules from activated T cells.

  1988cited by this paper
• Deficiency of lymphocyte function-associated antigen 3 (LFA-3) in paroxysmal nocturnal hemoglobinuria. Functional correlates and evidence for a phosphatidylinositol membrane anchor

  1987cited by this paper
• Inhibition of complement activation on the surface of cells after incorporation of decay-accelerating factor (DAF) into their membranes

  1984cited by this paper
• A simple and rapid method for the preparation of plasma membranes.

  1983cited by this paper

• (Patho)Physiology of Glycosylphosphatidylinositol-Anchored Proteins II: Intercellular Transfer of Matter (Inheritance?) That Matters

  2023cites this paper
• Novel biomimetic mesoporous silica nanoparticle system possessing targetability and immune synergy facilitates effective solid tumor immuno-chemotherapy.

  2022cites this paper
• Emerging nanomaterials for cancer immunotherapy

  2021cites this paper
• Metformin reduces PD-L1 on tumor cells and enhances the anti-tumor immune response generated by vaccine immunotherapy

  2021cites this paper
• Sensitizing solid tumors to CAR-mediated cytotoxicity using synthetic antigens

  2021cites this paper
• Surface Modification of E. coli Outer Membrane Vesicles with Glycosylphosphatidylinositol-Anchored Proteins: Generating Pro/Eukaryote Chimera Constructs

  2021cites this paper
• Dendritic Cells Pulsed with Cytokine-Adjuvanted Tumor Membrane Vesicles Inhibit Tumor Growth in HER2-Positive and Triple Negative Breast Cancer Models

  2021cites this paper
• Functional bionanomaterials for cell surface engineering in cancer immunotherapy

  2021cites this paper
• Tumor membrane-based vaccine immunotherapy in combination with anti-CTLA-4 antibody confers protection against immune checkpoint resistant murine triple-negative breast cancer

  2020cites this paper
• Tumor Membrane Vesicle Vaccine Augments the Efficacy of Anti-PD1 Antibody in Immune Checkpoint Inhibitor-Resistant Squamous Cell Carcinoma Models of Head and Neck Cancer

  2020cites this paper
• Strategies for Targeting Cancer Immunotherapy Through Modulation of the Tumor Microenvironment

  2019cites this paper
• Membrane insertion and intercellular transfer of glycosylphosphatidylinositol-anchored proteins: potential therapeutic applications

  2018cites this paper
• Biomedical applications of glycosylphosphatidylinositol-anchored proteins

  2016cites this paper
• vwF A3-GPI modification of EPCs accelerates reendothelialization of injured vessels via collagen targeting in mice

  2016cites this paper
• Therapeutic efficacy of PD-L1 blockade in a breast cancer model is enhanced by cellular vaccines expressing B7-1 and glycolipid-anchored IL-12

  2016cites this paper
• Plasma membrane vesicles decorated with glycolipid-anchored antigens and adjuvants via protein transfer as an antigen delivery platform for inhibition of tumor growth.

  2016influential citation
• Strategies for cell membrane functionalization

  2016cites this paper
• Influenza virus‐like particles engineered by protein transfer with tumor‐associated antigens induces protective antitumor immunity

  2015cites this paper
• The generation of a ZBTB16-inducible expression system in the ACHN adenocarcinoma cell line

  2015cites this paper
• Staphylococcal enterotoxin B/texosomes as a candidate for breast cancer immunotherapy

  2015cites this paper
• Personalized Diagnosis and Therapy

  2015cites this paper
• Texosome-anchored superantigen triggers apoptosis in original ovarian cancer cells

  2014cites this paper
• Staphylococcal entorotoxin B anchored exosome induces apoptosis in negative esterogen receptor breast cancer cells

  2014cites this paper
• Exosome/staphylococcal enterotoxin B, an anti tumor compound against pancreatic cancer.

  2014cites this paper
• Personalized Prognosis, Diagnosis and Therapy of Metabolic Diseases: Targets and Strategies

  2014cites this paper
• Lipid-Mediated Cell Surface Engineering

  2014cites this paper
• Immunotherapeutic strategies for cancer treatment: A novel protein transfer approach for cancer vaccine development

  2012cites this paper
• A novel vWF A3-GPI modified EPCs to enhance its adhesion ability to collegen

  2011cites this paper
• Immune Surveillance and Tumor Evasion

  2011cites this paper
• Novel applications for glycosylphosphatidylinositol-anchored proteins in pharmaceutical and industrial biotechnology

  2011cites this paper
• Chemokines, costimulatory molecules and fusion proteins for the immunotherapy of solid tumors.

  2011cites this paper
• Enhancement of specific cellular immune response induced by glycosyl-phosphatidylinositol-anchored BCR/ABL and mIL-12

  2011cites this paper
• Cancer vaccine development: designing tumor cells for greater immunogenicity.

  2010cites this paper
• Oral Protein Therapy for the Future – Transport of Glycolipid-Modified Proteins: Vision or Fiction

  2010cites this paper
• Surface Engineering of Biomembranes with GPI-Anchored Proteins and its Applications

  2010cites this paper
• Surface engineering of microparticles by novel protein transfer for targeted antigen/drug delivery.

  2009cites this paper
• Custom designing therapeutic cancer vaccines: Delivery of immunostimulatory molecule adjuvants by protein transfer

  2008cites this paper
• Rafts, anchors and viruses--a role for glycosylphosphatidylinositol anchored proteins in the modification of enveloped viruses and viral vectors.

  2008cites this paper
• Cytokine, chemokine, and co-stimulatory fusion proteins for the immunotherapy of solid tumors.

  2008cites this paper
• A Tapestry of Immunotherapeutic Fusion Proteins: From Signal Conversion to Auto-stimulation

  2008cites this paper
• The Glycosylphosphatidylinositol Anchor: A Complex Membrane-Anchoring Structure for Proteins†

  2008cites this paper
• Surface anchorage of superantigen SEA promotes induction of specific antitumor immune response by tumor-derived exosomes

  2007cites this paper
• Human tumor membrane vesicles modified to express glycolipid-anchored IL-12 by protein transfer induce T cell proliferation in vitro: a potential approach for local delivery of cytokines during vaccination.

  2006cites this paper
• B7-1-HSA (CD80-CD24), a recombinant hybrid costimulatory molecule retains ligand binding and costimulatory functions.

  2006cites this paper
• A novel bispecific tetravalent antibody fusion protein to target costimulatory activity for T-cell activation to tumor cells overexpressing ErbB2/HER2.

  2005cites this paper
• Modified cell ELISA to determine the solubilization of cell surface proteins: Applications in GPI-anchored protein purification.

  2005cites this paper
• Differential insertion of GPI‐anchored GFPs into lipid rafts of live cells

  2005cites this paper
• The novel chelator lipid 3(nitrilotriacetic acid)-ditetradecylamine (NTA(3)-DTDA) promotes stable binding of His-tagged proteins to liposomal membranes: potent anti-tumor responses induced by simultaneously targeting antigen, cytokine and costimulatory signals to T cells.

  2005cites this paper
• The α vβ 3 integrin as a tumor homing ligand for lymphocytes

  2004cites this paper
• Cancer vaccine development

  2004cites this paper
• Chemical modification of mammalian cell surfaces.

  2003cites this paper
• Anchoring Cytokines to Tumor Cells for the Preparation of Anticancer Vaccines Without Gene Transfection in Mice

  2003cites this paper
• [Cytotoxic T lymphocytes: role in immunosurveillance and in immunotherapy].

  2003cites this paper
• New designs for cancer vaccine and artificial veto cells

  2003cites this paper
• Glycolipid-anchored IL-12 expressed on tumor cell surface induces antitumor immune response.

  2002cites this paper
• Novel cancer vaccines prepared by anchoring cytokines to tumor cells avoiding gene transfection

  2002cites this paper
• A novel approach for modifying tumor cell‐derived plasma membrane vesicles to contain encapsulated IL‐2 and engrafted costimulatory molecules for use in tumor immunotherapy

  2002cites this paper
• GPI-anchoring of GM-CSF results in active membrane-bound and partially shed cytokine.

  2002cites this paper
• Does fusion of domains from unrelated proteins affect their folding pathways and the structural changes involved in their function? A case study with the diphtheria toxin T domain.

  2002cites this paper
• Prolonged display or rapid internalization of the IgG-binding protein ZZ anchored to the surface of cells using the diphtheria toxin T domain.

  2001cites this paper
• Induction of antitumor immunity via intratumoral tetra-costimulator protein transfer.

  2001cites this paper
• Tumour-induced suppression of immune response and its correction

  2001cites this paper
• Onset of ataxia and Purkinje cell loss in PrP null mice inversely correlated with Dpl level in brain

  2001cites this paper
• Interleukin 2-antibody and tumor necrosis factor-antibody fusion proteins induce different antitumor immune responses in vivo.

  2001cites this paper
• Development of therapeutic vaccines by direct modification of cell membranes from surgically removed human tumor tissue with immunostimulatory molecules.

  2001cites this paper
• Design of transgenes for efficient expression of active chimeric proteins on mammalian cells.

  2001cites this paper
• Designer cancer vaccines made easy: protein transfer of immunostimulatory molecules for use in therapeutic tumor vaccines.

  2001influential citation
• Ancrer des cytokines aux cellules cancéreuses à l’aide de la toxine diphtérique : mieux que l’immunothérapie par transfert de gène ?

  2001cites this paper
• Induction of Tumor-Specific Immunity in Mice by Immunization With Reconstituted Tumor Membrane Liposomes Containing Recombinant B7-2 (CD86)

  2000cites this paper
• Subcellular post-transcriptional targeting: delivery of an intracellular protein to the extracellular leaflet of the plasma membrane using a glycosyl-phosphatidyl inositol (GPI) membrane anchor in neurons and polarised epithelial cells

  2000cites this paper
• Characterization of a new human B7-related protein: B7RP-1 is the ligand to the co-stimulatory protein ICOS.

  2000cites this paper
• Hierarchical Costimulator Thresholds for Distinct Immune Responses: Application of a Novel Two-Step Fc Fusion Protein Transfer Method1

  2000cites this paper
• Expression and characterization of glycolipid-anchored B7-1 (CD80) from baculovirus-infected insect cells: protein transfer onto tumor cells.

  1999cites this paper
• MethodNovel Two-Step Fc Fusion Protein Transfer Distinct Immune Responses: Application of a Hierarchical Costimulator Thresholds for

  1999cites this paper